Life quality after orchiectomy of the bone metastatic prostate cancer patient
Nội dung chính của bài viết
Tóm tắt
Prostate cancer (PC) with bone metastasis has many clinical symptoms that very much affected to the patient’s quality of life (QoL). Improving cancer patient’s QoL is a mission for the health care professional workers. The study using questionaires SF-36 and UCLA-PCI-SF- a simple and common methods to evaluate the progress of orchiectomy treatment for bone metastases PC to assess the QoL and prostate-specific functions before and after orchiectomy. Clinical manifestations such as urinary tract, sexual function symptoms, anxiety, bone pain and insomnia affected the HRQoL (health related quality of life) of 53 participated patients were quite high from 69.8% up to 90.6%. After 1 month of orchiectomy, these symptoms were markedly reduced to less than 20%; Anxiety and Insomnia still affected 50.9% and 47.1% of study participant, respectively. HRQoL of 53 PC patients with bone metastasis after orchiectomy was remarkably improved. All domains of SF-36 and UCLA-PCI-SF after orchiectomy were statistically significantly increased with p-value < 0.05, except sexual bother.
Chi tiết bài viết
Từ khóa
HRQoL, orchiectomy, PC with bone metastasis, SF-36, UCLA-PCI-SF
Tài liệu tham khảo
2. Theriault RL, Theriault RL. Biology of bone metastases. Cancer Control. 2012;19(2):92-101.
3. Gandaglia G, Karakiewicz PI, Briganti A, et al. Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer. European Urology. 2015;68(2):325-334. doi:10.1016/j.eururo.2014.07.020
4. Lipton A. Implications of Bone Metastases and the Benefits of Bone-Targeted Therapy. Seminars in Oncology. 2010;37:S15-S29. doi:10.1053/j.seminoncol.2010.10.002
5. Zhang X, Zhang G, Wang J, et al. Luteinizing hormone-releasing hormone agonists versus orchiectomy in the treatment of prostate cancer: A systematic review. Frontiers in Endocrinology. 2023;14. Accessed November 14, 2023. https://www.frontiersin.org/articles/10.3389/fendo.2023.1131715
6. Walz S, Maas M, Stenzl A, et al. Bone Health Issues in Patients with Prostate Cancer: An Evidence-Based Review. World J Mens Health. 2020;38(2):151-163. doi:10.5534/wjmh.190044
7. Litwin MS, Shpall AI, Dorey F, et al. Quality-of-Life Outcomes in Long-Term Survivors of Advanced Prostate Cancer. American Journal of Clinical Oncology. 1998;21(4):327.
8. Sonn GA, Sadetsky N, Presti JC, et al. Differing Perceptions of Quality of Life in Patients With Prostate Cancer and Their Doctors. Journal of Urology. 2013;189(1S):S59-S65. doi:10.1016/j.juro.2012.11.032
9. Ratti MM, Gandaglia G, Alleva E, et al. Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review. Eur Urol Oncol. 2022;5(2):153-163. doi:10.1016/j.euo.2021.10.004-KL
10. Drudge-Coates L, Oh WK, Tombal B, et al. Recognizing Symptom Burden in Advanced Prostate Cancer: A Global Patient and Caregiver Survey. Clin Genitourin Cancer. 2018;16(2):e411-e419. doi:10.1016/j.clgc.2017.09.015
11. Gartrell BA, Saad F. Managing bone metastases and reducing skeletal related events in prostate cancer. Nat Rev Clin Oncol. 2014;11(6):335-345. doi:10.1038/nrclinonc.2014.70
12. Nishimura K. Management of bone metastasis in prostate cancer. J Bone Miner Metab. 2023;41(3):317-326. doi:10.1007/s00774-023-01435-w
13. Porreca A, Noale M, Artibani W, et al. Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study. Health Qual Life Outcomes. 2018;16:122. doi:10.1186/s12955-018-0952-5